UK-based pharmaceutical company AstraZeneca and Japan-based Takeda Pharmaceuticals are reported to have formed a consortium to bid for a license to run a biotech incubator which is being set up under Israel’s Technological Incubators Program.
Other bidders include a consortium of US-based healthcare company Johnson & Johnson and venture capital firm OrbiMed.
There are 24 incubators in Israel to date, out of which 22 are technological incubators, 1 is a technology-based industrial incubator and 1 is a designated biotech incubator.